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From Systemic T Cell Self-Reactivity
to Organ-Specific Autoimmune Disease
via Immunoglobulins
Introduction
Rheumatoid arthritis (RA) is a frequent and incapacitat-
ing autoimmune disorder (Feldmann et al., 1996b). It is
a chronic, progressive joint disease, characterized by
Anne-Sophie Korganow,1,2,7 Hong Ji,1,7
Sara Mangialaio,1 VeÂ ronique Duchatelle,3
Roberta Pelanda,4,8 Thierry Martin,2
Claude Degott,3 Hitoshi Kikutani,5
Klaus Rajewsky,4 Jean-Louis Pasquali,2
leukocyte invasion of the synovial lining and hyperplasiaChristophe Benoist,1,6 and Diane Mathis1,6
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tion of cytokines and other soluble mediators results inMoleÂ culaire et Cellulaire
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manifestations can also occurÐin particular, the pro-67404 Illkirch
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The etiology and pathogenesis of RA remain contro-France
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portant role for T cells (Panayi et al., 1992; Fox, 1997),France
B cells (Zvaifler, 1973), and other leukocytes such as3 Service d'Anatomie Pathologique
dendritic cells, macrophages, and neutrophils (FiresteinHoÃ pital Beaujon
and Zvaifler, 1990; Feldmann et al., 1996a; Thomas et92110 Clichy
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factors. RA is a heterogeneous syndrome, different pa-Institut fuÈ r Genetik der UniversitaÈ t
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Recently, we reported a mouse model that spontane-Osaka University
ously develops a disease with many of the characteris-3-1 Yamada-oka, Suita
tics of rheumatoid arthritis in humans (Kouskoff et al.,Osaka 565
1996). All KRN T cell receptor (TCR) transgenic (tg) miceJapan
on the C57Bl/6xNOD genetic background (K/BxN mice)
develop a joint disorder, starting at 3 to 4 weeks of
age and rapidly evolving until the animal's mobility is
Summary severely compromised; as in patients, the disease is
chronic, progressive, symmetrical, and has a proximal
Rheumatoid arthritis is a common and debilitating au- to distal gradient of severity. The murine disease exhibits
toimmune disease whose cause and mechanism re- all of the major histological features of the human one:
main a mystery. We recently described a T cell re- leukocyte invasion, synovitis, pannus formation, carti-
ceptor transgenic mouse model that spontaneously lage and bone destruction, and anarchic remodeling.
develops a disease with most of the clinical, histologi- The mouse model, like patients, shows several immuno-
cal, and immunological features of rheumatoid arthri- logical abnormalities, including cytokine (TNF-a, IL-6)
tis in humans. Disease development in K/BxN mice is imbalances and B cell hyperactivity, the latter manifest
initiated by systemic T cell self-reactivity; it requires as an increase in B cell numbers, hypergammaglobu-
T cells, as expected, but B cells are also needed, more linemia, and autoantibody production. Despite these
surprisingly. Here, we have identified the role of B cells marked similarities, the murine and human disorders do
as the secretion of arthritogenic immunoglobulins. We diverge in certain details: a more aggressive disease in
suggest that a similar scenario may unfold in some the mice, a few differences in the particular joints af-
other arthritis models and in human patients, begin- fected, a different spectrum of autoantibodies pro-
ning with pervasive T cell autoreactivity and ending in ducedÐin particular, absence in the mice of immuno-
globulin (Ig) M isotype rheumatoid factor (RF: antibodyimmunoglobulin-provoked joint destruction.
[Ab] directed against the Fc portion of IgG). Nonetheless,
given the similarities to the human disease, a 100%
incidence, and a highly reproducible course of patho-
6 To whom correspondence should be addressed (e-mail: cbdm@
genesis, we felt that the K/BxN model would be valuableigbmc.u-strasbg.fr [C. B. and D. M.]).
for elucidating mechanisms of RA pathogenesis.7 These authors contributed equally to this work.
The mouse model was generated when the KRN/8 Present address: Max-Planck Institute for Immunobiology, StuÈ be-
weg 51, 79108 Freiburg, Germany. C57Bl/6 TCR tg line was fortuitously crossed with the
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Table 1. KRN Arthritis Transfer
Fraction with
Donor Recipient Arthritis Day of Onset
K/B BxN-Cao/o 12/12 6.4 6 0.7
B BxN-Cao/o 0/5 Ð
K/BxN BxN-RAGo/o 7/7 8.3 6 2.3
K/BxN B-RAGo/o 48/49 11.8 6 2.4
K/B B-RAGo/o 0/4 Ð
T2 K/BxN B-RAGo/o 1/6 transient
B2 K/BxN B-RAGo/o 0/6 Ð
(T2 K/BxN) 1 (B2 K/BxN) B-RAGo/o 5/6 17.8 6 3
(K/B)CD41 1 (BxN-Cao/o)B2201 BxN-RAGo/o 4/4 14,19,21,21
(K/B)CD41 1 (B-Cao/o)B2201 BxN-RAGo/o 0/4 Ð
APC B
K/B (BxN-RAGo/o) 1 B2201BM(BxN-Cao/o) bxg7 bxg7 2/2 7,10
K/B (BxN-RAGo/o) 1 B2201BM(B-Cao/o) bxg7 b 0/2 Ð
NOD strain (Kouskoff et al., 1996). This was a surprising up and presented by other antigen-presenting cells
(APCs). Third, B cells could play their critical role inresult given that the KRN receptor was known to recog-
Ag presentation. This might be independent of their Ignize a peptide of bovine ribonuclease in the context
specificities, as B cells may process some Ags differ-of major histocompatibility complex (MHC) class II Ak
ently from other APCs (Vidard et al., 1992) and maymolecules, both absent from the F1 offspring, but we
elicit different effector functions in responding T cellseventually determined that the disease is initiated by
(Stockinger et al., 1996). Or it might be critically depen-cross-reactive recognition of NOD-derived Ag7 mole-
dent on Ig specificity: Ags internalized after binding tocules by the KRN TCR. Thus, in K/BxN animals, a situa-
surface Igs on B cells are processed and presented bytion of systemic autoreactivity is generated, raising two
class II molecules with significantly enhanced efficiency,central issuesÐhow T cells expressing the KRN speci-
as are Ags complexed with secreted Igs and internalizedficity escape tolerance induction and how organ-spe-
by other APCs via binding to Fc receptors (Amigorenacific autoimmune disease develops in the presence of
and Bonnerot, 1998). Finally, it could be that a particularsystemic autoreactivity. Concerning the first issue, we
B cell product plays a directly pathogenic role. Again,found evidence for multiple levels of tolerance induc-
likely candidates are Igs, which might promote arthritistionÐthymocyte clonal deletion, diminished levels of
because of their particular specificities or simply dueTCR clonotype due to selection of cells exhibiting in-
to overproduction. Other possibilities include solublecomplete allelic exclusion, clonal anergy of peripheral
mediators like cytokines.T cellsÐbut none of these was completely effective.
Concerning the second, we began to dissect pathoge-
Arthritis Transfer Systemsnetic mechanisms by identifying the critical cellular play-
Disease transfer systems have been useful tools forers. Not surprisingly, T cells were required for arthritis
unraveling mechanisms of autoimmune pathogenesis.development, although they appeared dispensable at
Thus, as a first step in identifying the role of B cells inthe later stages of disease. Rather unexpectedly, B cells
arthritis development in K/BxN mice, we establishedwere also critical. Here, after evaluating a number of
two transfer protocols.possibilities, we have identified the role of B cells in the
In the first (Table 1), 2 3 107 splenocytes from healthydevelopment of arthritis in K/BxN mice.
K/B donors were injected intravenously (i.v.) into BxN-
Cao/o hosts devoid of a:b T cells. Within 8 days, all recipi-
Results ents had developed an arthritis clinically and histologi-
cally indistinguishable from that of K/BxN mice. None
B cells could play several possible roles during the un- of the control recipients injected with B6 splenocytes
folding of arthritis in K/BxN mice. First, it could be that showed signs of disease. This system permits conve-
B cells exert only an indirect effect on disease develop- nient analysis of the K/BxN disease in its entirety, from
ment influencing, for example, the genesis of lymphoid initiation through all stages of pathogenesis.
organs or the composition of the cytokine/chemokine The second system (Table 1) focuses on the effector
milieu. Indeed, it is known that B cell-deficient mice phases of disease, after the KRN T cells have already
have aberrant lymph node architecture (Fu et al., 1998), been confronted with Ag. BxN-RAGo/o hosts, lacking all
and such indirect effects may explain a critical B cell mature lymphocyte subsets, were injected i.v. with 2 3
influence on prion disease (Klein et al., 1998). Second, 107 splenocytes from arthritic K/BxN donors; by 11 days,
it could be that the Ag recognized by KRN T cells to all recipients had succumbed to the typical arthritis.
initiate disease is synthesized only by B cells. Igs are Interestingly, this protocol also worked, after a slight
obvious candidates, and their particular specificities delay, with B-RAGo/o recipients, indicating that arthritis
might or might not be important, but there are plenty of development does not require Ag7-mediated presenta-
other possibilities. The arthritogenic Ag might be pre- tion of the Ag on resident synovial fibroblasts or chon-
drocytes, at least in the effector phases.sented by B cells themselves or be shed and then taken
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Although B cell±deficient K/BxN-mMo/o mice do not
develop arthritis, and we confirmed that BxN-mMo/o
hosts transferred with K/B splenocytes do not either
(S. M., unpublished data), it was not known whether
B cells are still required during the effector phases of
disease. According to the results depicted in Table 1,
they are: K/BxN splenocytes depleted of either T or
B cells were unable to transfer arthritis into B-RAGo/o
recipients.
These two transfer systems, both B cell dependent,
should facilitate the dissection of pathogenetic mecha-
nisms. Their advantages vis a vis the regular model are
their relative synchrony, rapidity, and manipulability.
An Indirect Role?
To rule out the possibility that B cells play only an indirect
role in the K/BxN model, we demonstrated that an Ag7-
restricted B cell function is critical. The data presented
in Table 1 show that arthritis development requires more
than the mere presence of B cellsÐrather, B cells ex-
pressing Ag7 molecules are needed. In the first set of
experiments, purified CD41 T cells from K/B mice, when
complemented with purified B2201 B cells displaying
Ab plus Ag7 (BxN-Cao/o) but not just Ab (B-Cao/o) molecules,
precipitated disease in BxN-RAGo/o hosts devoid of lym-
phocytes. In the second experiment, B cells expressing
either Ab plus Ag7 or Ab alone were generated in RAGo/o
mice by transfer of bone marrow cells harboring B cell
progenitors, and 6 weeks later, once the B cell compart-
ment had been reconstituted, the mice were injected
with K/B splenocytes. Only those animals whose B cells
displayed Ag7 molecules became arthritic. Clearly, then,
the role of B cells in the K/BxN model is not merely an
indirect influence on the general development or func-
tioning of the immune system. An Ag7-restricted B cell
function is required, most likely a B/T cell interaction as
occurs during B cell delivery of Ag to T cells, either to
stimulate them or in eliciting their help for Ig production.
Dependence on Ig Specificity?
As detailed above, each of the three putative roles in-
volving a more direct input from B cellsÐAg synthesis,Figure 1. Disease Development in K/BxN Mice with a Restricted B
Ag presentation, and synthesis of a particular productÐCell Repertoire
could rely on a mechanism dependent on or indepen-(A) Arthritis incidence in mice carrying various Ig knockin alleles.
Genotypes at the m and k loci are indicated on the left: black square, dent of Ig specificities. Thus, establishing whether arthri-
homozygosity for the knockin allele; half-black square, heterozygos- tis development in K/BxN mice is influenced by the Ig
ity; white square, homozygosity for the normal allele. Arthritis was repertoire would expeditiously rule out a number of pos-
evaluated by inspection of the joints and measurement of ankle sible mechanisms.
thickness, and the mice were categorized as presenting the usual
To do this, we analyzed K/BxN animals with a re-K/BxN arthritis, arthritis with delayed onset (onset .35 days), or
stricted B cell repertoire. Due to the dictates of allelicbeing arthritis free, the absence of disease being confirmed by
histology. exclusion, it is possible to substantially reduce an ani-
(B) Representative plots of ankle thickness in K/BxN mice carrying mal's Ig heavy chain repertoire by inserting a rearranged
different Ig knockin alleles: only wild-type alleles (open squares); VHDHJH segment into the germline JH locus, and the rep-
heterozygous for either the m or k knockin allele or both (open ertoire is further constrained if both chromosomes carry
circles); homozygous for either the m or k knockin allele (black cir-
the ªknockinº allele (Taki et al., 1993). Similarly, thoughcles); homozygous for both (closed squares). The dashed line shows
less drastically, the Ig light chain repertoire can be re-the maximum value for healthy control mice at these ages.
(C) Numbers of splenic IgM1B2201 B cells, determined by cytofluori- duced by introducing a rearranged VKJK segment into
metry, shown relative to non-TCR tg littermates to standardize for the germline JK locus, again most effectively when the
variations in the ages of the mice. Each point represents a single alteration is present on both chromosomes (Zou et al.,
tg:non-TCR tg littermate pair. 1993). We made use of two existing mouse lines, one
(D) Serum IgG levels, measured by ELISA, in several of the knockin
carrying a knockin of the VHB1-8-DH-JH2 segment en-mice grouped as described above. N, normal onset; D, delayed
coding the heavy chain variable region of an anti-onset; P, arthritis free. Each bar represents an individual mouse.
(4-hydroxy-3 nitrophenyl)-acetyl (NP) Ab (Sonoda et al.,
Immunity
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1997), and the other a Vk3-83-Jk2 segment specifying
the light chain variable region of an anti-MHC class I
(H-2Kb, Dk,b) Ab (Pelanda et al., 1996). These were
crossed appropriately to produce K/BxN animals car-
rying knockins in the heterozygous or homozygous state
at the heavy and/or light chain locus.
Figure 1A summarizes the genotypes and phenotypes
of these mice, and some typical plots of disease course
are presented in Figure 1B. The major point to emerge
from these data is that, as the Ig repertoire becomes
more and more restricted, arthritis is delayed and even-
tually abrogated. Almost all animals with at least one
wild-type allele at both the heavy and light chain loci
developed arthritis, a substantial number at the normal
time of onset. A large majority of animals with homozy-
gous knockin alleles at either one or the other Ig locus
also succumbed to arthritis, but in all cases disease
onset was delayed. The delayed disease often showed
diminished severity, with mild or asymmetrical joint
swelling for several days; nonetheless, in most cases,
all four paws were eventually afflicted and became de-
formed. Finally, none of the mice with homozygous
knockin alleles at both Ig loci developed arthritis, at
least until 100 days of age.
We also analyzed the B and T cell compartments of
K/BxN mice with the various knockin genotypes. In all
cases, even disease-free animals with a highly restricted
Ig repertoire, there were reduced numbers of mature
CD41 T cells and a diminished fraction of cells express-
ing high levels of the transgene-encoded TCR (data not
shown). There was also an enrichment for T cells dis-
playing late activation markers (data not shown). These
observations are reminiscent of findings on the T cell
Figure 2. Activation of KRN T Cells in the Absence of B Cells
compartment of regular K/BxN mice (Kouskoff et al.,
(A) Surface expression of the CD44 late activation marker on gated
1996) and indicate that the first step of disease, KRN T CD41 lymph node cells, in non-TCRtg BxN littermates, and in TCR
cell recognition of the potentially arthritogenic antigen, tg K/BxN mice heterozygous (with a normal B cell complement) or
takes place in all of the knockin animals. Again in all homozygous (B cell deficient) for the mMo mutation.
(B) Division of CFSE-labeled K/B splenocytes after injection intocases, B cell differentiation appeared essentially normal,
non-TCR tg recipients, having B cells (BxN) or not (BxN-mMo/o). Divi-according to cytofluorimetric analysis of spleen and
sion was measured as dilution of CFSE staining intensity inperitoneal cells with anti-B220, -IgM, -IgD, -Mac-1,
CD41Vb61 cells that had homed to the axillary lymph nodes, mea-
and -CD5 reagents (data not shown). As expected from sured by cytofluorimetry at different times after transfer.
previous results on regular K/BxN mice, B lymphocyte
numbers were elevated almost 3-fold in arthritic knockin
animals with partially restricted Ig repertoires; more sur- First, we analyzed the activation status of KRN T cells
prisingly, they were also higher, although only about residing in B cell±deficient K/BxN-mMo/o mice by quanti-
1.5-fold, in disease-protected animals with a highly re- tating surface levels of the late activation marker CD44.
stricted Ig repertoire (Figure 1C). While almost all ar- As described previously (Kouskoff et al., 1996) and illus-
thritic animals also exhibited hypergammaglobulinemia, trated in Figure 2A, elevated numbers of actived T cells
those that were disease-free because of a constrained are found in arthritic K/BxN mice vis a vis healthy non-
Ig repertoire did not, although they did show Ig class TCRtg BxN littermates. More activated T cells were also
switching (Figure 1D). observed in K/BxN-mMo/o animals (Figure 2A), despite
Thus, arthritis development in K/BxN mice relies criti- the fact that they will never develop arthritis. In addition,
cally on B cells with particular Ig specificities, although as in regular K/BxN mice, KRN thymocytes were subject
certain of the early disease manifestations appear less to clonal deletion in K/BxN-mMo/o animals (data not
dependent. Several of the possible mechanisms evoked shown).
above are thereby ruled out. We also looked more directly at KRN T cell priming.
Splenocytes isolated from K/B animals were labeled
with 5, 6 carboxyfluorescein diacetate succinimidyl es-A B Cell±Specific Antigen?
To evaluate the possibility that the K/BxN model re- ter (CFSE). This fluorescent dye is incorporated in the
cytosol and stably maintained, so that with subsequentquires B cells simply because the Ag recognized by the
KRN receptor is synthesized only by that cell type, we cell divisions its concentration is successively halved, a
reduction that is readily apparent upon cytofluorimetricasked whether KRN T cells see their Ag in mice devoid
of B cells. analysis. The labeled splenocytes were transferred into
Arthritogenic Igs
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various recipients, and at progressively later times, the
axillary lymph nodes were removed and CFSE levels in
CD41 Vb61T cells assessed. As illustrated in Figure 2B,
while the cells did not divide after transfer into control
B6 recipients, substantial division took place when they
were introduced into F1 animals containing (BxN) or
lacking (BxN-mMTo/o) B cells. The parallel kinetics and
similar degree of division in the two cases indicate that
T cell stimulation was not just due to B cells in the
innoculum.
According to these two criteriaÐlong-term stimula-
tion of resident cells and priming of naive cellsÐT cells
expressing the KRN receptor recognize their Ag in the
absence of B cells. Thus, synthesis of the arthritogenic
Ag cannot be confined uniquely to B cells.
Ag Presentation?
That arthritis development in K/BxN mice depends on
an Ag7-restricted B cell function (Table 1) argues for the
importance of a cognate interaction between the KRN
TCR and MHC molecules on B cells, either in promoting
T cell stimulation or in eliciting T help for Ig production.
The fact that KRN T cells can be efficiently primed and
maintained in an activated state in the complete ab-
sence of B cells (Figure 2) indicates that B cells are not
solely responsible for T cell stimulation. To evaluate
the necessity for T help-dependent Ig production, we
determined whether and when the K/BxN disease de-
pends on CD40 expression by B cells, given that CD40/
CD40L interactions are known to be critically involved
in the delivery of T cell help (Clark et al., 1996).
The data presented in Figure 3 indicate that arthritis
development requires CD40 display on B cells. K/BxN
mice carrying a null mutation at the CD40 locus did not
develop arthritis (A). Nor did they exhibit the hypergam-
maglobulinemia characteristic of regular K/BxN animals
(B). Yet they did show some early signs of the disease
process, such as increased B cell numbers (C) and acti-
vation of KRN T cells (D). (In addition, the usual clonal
Figure 3. Dependence of the K/BxN Model on CD40 Expression bydeletion of KRN thymocytes was detected [data not
B Cellsshown]).
(A) Arthritis incidence in K/BxN littermates, heterozygous (phenotyp-Given that CD40 can be expressed on cell types other
ically wild-type) or homozygous (CD40-deficient) for the CD40than B cells (e.g., macrophages, dendritic cells, and
knockout mutation. Arthritis was evaluated by inspection of the
endothelial cells), it was important to establish that the joints and measurement of ankle thickness, as in Figure 2A. The
absence of disease in the mutant animals was due to time of onset and severity of arthritis in K/BxN-CD401/o mice were
the absence of CD40 on B cells, and this was done via indistinguishable from those in regular K/BxN mice.
(B and C) B cells in KRN TCR tg mice and non-TCRtg littermatesa series of transfer experiments (Figure 3E). Splenocytes
on the BxN background, with or without a CD40 deficiency. (B)from K/BxN-CD40o/o mice were unable to provoke arthri-
Serum IgG levels as determined by ELISA; (C) numbers of splenictis in CD40-positive BxN-RAGo/o recipients, suggesting
IgM1B2201 cells. Standardization as for Figure 2; each point orthat expression of CD40 on non-B APCs does not suffice
bar represents an individual mouse.
for disease development. That the T cells from CD40- (D) T cell activation, assessed as surface expression of CD44 on
negative mice were not somehow incompetent was gated CD41 lymph node cells.
ruled out because purified CD41 cells from K/BxN- (E) Cell transfers establishing the need for CD40 expression on B
cells. Donor cells were: top experiment, total splenocytes; middle,CD40o/o animals could provoke disease in CD40-positive
1 3 106 positively enriched CD41 T cells; bottom, 2 3 106 CD41 TBxN-Cao/o recipients. Rather, the problem lies with the B
cells plus 5 3 106 B2201 B cells, both positively enriched.cells lacking CD40: they could not interact with purified
CD41 cells from CD40-positive K/B6 mice to precipitate
disease in BxN-RAGo/o recipients, also CD40-positive.
A B Cell Product?Taken together, the data in Table 1 and Figures 2 and
To explore the possibility that arthritis development in3 argue that arthritis development in K/BxN mice needs
this model depends critically on a particular B cell prod-an Ag7-restricted, CD40-dependent T/B cell interaction
uct, we tried to provoke disease in B cell±deficientdownstream of initial T cell stimulation. A likely possibil-
K/BxN-mMo/o mice by serum transfer. Severe joint swell-ity is a requirement for T/B collaboration in the produc-
tion of Igs. ing appeared in the animals injected with serum from
Immunity
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arthritic K/BxN donors but not in those receiving serum
from nonarthritic BxN controls (Figure 4A). Similar re-
sults were obtained upon injecting sera from arthritic
and nonarthritic donors into lymphocyte-deficient RAGo/o
hosts (see below). Disease could be induced with as
little as 100 ml of K/BxN serum and showed up in all 32
of the B cell±deficient or lymphocyte-deficient hosts
injected. Disease was provoked very rapidly, measured
by either clinical score or ankle thickness, evident by
the former already within 2 days after serum injection
(Figure 4B).
The arthritis provoked by serum transfer presented
all of the histological features of the disease in regular
K/BxN mice, including invasion of inflammatory cells,
hyperplasia of synoviocytes, pannus formation, and car-
tilage destruction (Figures 5A and 5B). However, the
transfered disease was somewhat more heterogeneous,
in that neighboring joints could differ greatly in the sever-
ity of their histological lesionsÐcompare for example
Figures 5C and 5D. This variability probably reflects the
one striking difference between the serum-induced and
spontaneous diseasesÐthat is, the induced arthritis
was transient. In mice that had received a single pair
of injections, joint inflammation began to subside after
about 15 days (Figure 4C); after 30 days, some of the
joints appeared quite normal, even in the animals that
had initially been fully arthritic. Histology of such joints
(Figures 5E and 5F) revealed minimal leukocyte infiltra-
tion and synoviocyte hyperplasia and intact cartilage
showing clear evidence of regeneration. Interestingly,
disease transience could be overcome by repeated in-
jections of serum from arthritic mice, as measured by
either clinical score or ankle thickness (Figure 4C). That
this was true even for RAGo/o recipients suggests that
Ig instability is the explanation for the transient nature
of the disease, rather than the absence of a critical input
from disease-specific T or B cells.
To test whether the arthritogenic serum factor was an
Ig, we fractionated serum from K/BxN mice into IgG and
non-IgG components and tested their disease-inducing
capacity. Only the IgG fraction was capable of provoking
arthritis in RAGo/o hosts, and its potency was similar to
that of whole serum (relative to the starting volume)
(Figure 4D), as were the histological features of the dis-
ease it induced (data not shown). The arthritogenic prop-
erty of K/BxN Igs could be due to either their elevated
concentration, about 10-fold higher than in serum from
normal mice, or to their particular specificities. However,
(C) Wane of arthritis, read out as clinical index or ankle thickness,
after a short course of K/BxN serum administration (open circles),
but persistence after repeated injection (black circles). Recipients
were RAGo/o mice.
(D and E) Arthritogenic activity of the serum IgG fraction. (D) RAGo/o
Figure 4. Arthritis Provoked by Transfer of IgG from Arthritic K/BxN mice were injected with similar amounts (relative to starting volumes)
Mice of serum from arthritic K/BxN mice (stars), the flow-through (crosses)
or the fraction eluted from a protein-G column (closed circles). (E)(A) Hind limbs of 6-week-old K/BxN-mMo/o mice 7 days after injection
of 2 3 250 ml serum from an arthritic K/BxN mouse or from a BxN Twice the amount of IgG from non-TCR tg littermates was incapable
of inducing arthritis.control littermate.
(B) Clinical index and ankle thickness in several RAGo/o mice injected (F) Inactivity of anti-cII Abs. The low level of anti-cII Abs detected
at the lowest dilution of one of the K/BxN sera cannot account forwith serum from arthritic K/BxN mice or with control serum. The
clinical sore is defined as: 0, normal; 1, doubt; 2, two paws affected; the disease transfer, as a 30-fold excess of the CIA serumÐmatched
relative to cII IgGÐcould not provoke disease in two recipients.3, three paws affected; and 4, all limbs affected.
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Figure 5. Histological Features of Ig-Induced
Arthritis
(A and B) Knee sections from a typical K/BxN
mouse (A) or a K/BxN-mMo/o mouse 10 days
after two injections of 200 ml serum from an
arthritic K/BxN animal (B). Note in both cases
the thickened synovial lining, the massive un-
derlying inflammatory infiltration, which ex-
tends over the cartilage and begins its destruc-
tion and the presence of polymorphonuclear
cells in the articular cavity. Hematoxylin and
eosin (H1E) staining, 103 objective.
(C and D) Heterogeneity of serum-induced
disease. Two sections from the same RAGo/o
mouse 8 days after transfer of serum from
arthritic K/BxN mice. The ankle (C) presents a
very agressive form of disease with the same
histological picture as described above, while
the tarsal joint (D) is intact. H1E staining, 103
objective.
(E and F) Recovery from joint histopathology
after a single administration of serum. (E) Sec-
tion of an ankle, 35 days after administration
of serum from arthritic K/BxN mice. The artic-
ular cavity is now clear of neutrophils; the
synovial lining is still slightly thickened, but
the underlying inflammatory infiltrate has al-
most completely subsidedÐsave for a small
area (star). (F) The articular cartilage appears
to be regenerating, showing a rough but free
surface, and images evoking dividing chon-
drocytes (juxtaposed chondrocyte lacunae,
two cells per lacuna; arrows; 403 objective).
when we directly compared disease induction with Igs product provokes arthritis reproducibly, amazingly rap-
idlyÐthough transientlyÐand in the complete absencefrom K/BxN mice versus double the amount from control
animals, we found the former and never the latter to be of lymphocytes.
effective (Figure 4E).
Type II collagen (cII) is a popular candidate autoanti-
gen for rheumatoid arthritis. It seemed plausible, then, A Secondary Role for T Cells
Injection of serum (or Igs) from arthritic K/BxN micethat the arthritogenic Igs might be anti-cII Abs, and so
we assayed sera from arthritic K/BxN mice for reactivity into RAGo/o animals precipitated arthritis indicating that,
once produced, the arthritogenic Igs do not absolutelyto bovine or rat type II collagen, the latter being highly
homologous to its mouse counterpart. We did detect require KRN T cells, other T or B cells, or Ag7 molecules
to provoke disease (e.g., Figures 4B±4F; Figures 5C andmarginal titers of anti-cII Abs in sera from K/BxN ani-
mals, about 103-fold lower than in sera from positive- 5D). Yet, we noted that a more severe arthritisÐmeasured
by clinical score, ankle thickness, or histologyÐusuallycontrol mice with collagen-induced arthritis (CIA) and
not significantly higher than in sera from negative-con- developed after serum transfer into K/BxN-mMo/o ani-
mals. To better understand this phenomenon, we di-trol BxN mice when corrected for Ig concentration.
Nonetheless, we directly tested the pathological rele- rectly compared disease development in different types
of recipients, all on the BxN genetic background; repre-vance. In parallel, RAGo/o mice were injected with serum
from arthritic K/BxN donors or from donors with CIA, sentative results from one such comparison of several
are presented in Figure 6. K/BxN-mMo/o recipients almostboth sera having been titred for anti-cII Abs. Only in the
former case was arthritis provoked in the recipients, always developed the most severe arthritis. In particular,
compared with BxN-mMo/o animals, their disease waseven though in the latter over 30-fold more anti-cII Abs
were transferred (Figure 4F). more persistent (left panel), more inflammatory (right
panel), and more aggressive histologically (data notThus, a B cell product is key to arthritis development
in K/BxN mice. The arthritogenic product is one or more shown), indicating that KRN T cells still have an influence
even in the late stages of disease. On the other hand,Igs of a particular specificity, which is not anti-cII. The
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leaves us to apply more systematic methods of charac-
terizing Ab reactivities, which are in progress but which
will be laborious given the necessity of proving the
pathogenic relevance of any antigen so identified.
Second, how do these particular Ig specificities come
to be produced? T cells expressing the KRN receptor
can recognize essentially any cell displaying Ag7 mole-
cules (Kouskoff et al., 1996; data not shown). Thus, KRN
T cells should be able to provide help to the entire reper-Figure 6. Secondary Role for T Cells in the Ig-Induced Disease
toire of B cells, as they all display MHC class II mole-Arthritis was induced by transfer of serum from arthritic K/BxN mice
cules, as well as CD40. However, polyclonal B cell acti-into different recipients, all on the BxN genetic background: non-
vation is too simple an explanation for disease in theTCR tg wild-type, non-TCR tg B cell±deficient (mMo/o), non-TCR tg
lymphocyte-deficient (RAGo/o) or KRN TCR tg B cell±deficient K/BxN model as other polyclonal activators do not elicit
(K/BxN-mMo/o). the aggressive and isolated arthritis characteristic of
these mice. There has to be selectivity to the stimulation,
at least at the level of Ig production. Which B cells
secrete Igs in K/BxN mice probably depends on a num-BxN-RAGo/o recipients routinely developed a more se-
ber of factors. The first is that their surface Ig recep-vere arthritis than either BxN-mMo/o or BxN mice, and
tors must be engaged, since isolated TCR:MHC andBxN-mMo/o recipients a stronger disease than BxN ani-
CD40L:CD40 interactions are not sufficient to push Bmals, suggesting that non-KRN T cells and other B cells
cells to Ig production in vivo (Cooke et al., 1994). Thisor Igs might have an inhibitory effect.
implies that only those cells with specificities directed
at self-antigens or coincidentally expressed foreign anti-Discussion
gens should become Ig secretors. An important factor
for the potentially self-reactive B cells is whether andTaking all of the data into account, we favor the following
how they are tolerized. For example, the noncognatescenario. (1) T cells expressing the KRN receptor recog-
help provided by KRN T cells may interfere with thenize a self-peptide in the context of Ag7 molecules dis-
usual deletion or inactivation of newly generated autore-played on peripheral APCs and become activated. The
active B cells (Cooke et al., 1994; Fulcher et al., 1996),critical APCs are probably dendritic cells and/or macro-
may ªawakenº a fraction of cells that had been renderedphages as this process does not require display of Ag7
anergic, in particular those recognizing polymeric oron B cells nor on synovial fibroblasts or chondrocytes
membrane-bound Ags (Cooke et al., 1994), or may acti-(Figure 2; Table 1; data not shown). (2) Activated KRN
vate those autoreactive B cells that are not normallyT cells interact with B cells through TCR:Ag7 and
tolerized themselves but remain innocuous becauseCD40L:CD40 engagements, promoting further T cell
their T cell partners responsible for providing cognatestimulation, polyclonal B cell activation, and T help-
help have been deleted or inactivated (Adelstein et al.,
dependent Ig overproduction (Table 1; Figure 3). (3)
1991; Hannum et al., 1996). On the other hand, help
Among the Igs produced, some bind to joint constit-
from KRN T cells should not elicit Ig secretion from
utents and precipitate arthritis, this process depending
the fraction of anergic B cells that dies in response to
critically on particular Ig specificities (Figures 1, 4, and subsequent encounter with Ag in the presence of T cell
5; data not shown). Ab/Ag complexes could be patho- help (Cooke et al., 1994; Rathmell et al., 1995). Finally,
genic via several mechanisms: direct perturbation of a factor recently shown to influence autoantibody pro-
joint structures; activation of the complement cascade, duction is the cytokine milieu: generation of some anti-
resulting in cell lysis and production of inflammatory self-specificities in pristane-injected mice is regulated
mediators; and engagement of Fc receptors, inducing by IL-6, while production of others is not (Richards et
activation of local cells. (4) While arthritogenic Igs can al., 1998). This complexity of factors probably underlies
precipitate arthritis in the absence of T cells expressing the narrow manifestation of autoimmunity in K/BxN
the KRN receptor, indeed without any lymphocytes pres- mice; the critical task now is to identify which ªsliceº of
ent at all, KRN T cells can intensify disease (Figure 6). B cell tolerance is broken by KRN T cell±mediated help,
This proposed scenario raises three key questions. and why.
First, what are the specificities of the arthritogenic Igs? Third, can the role of B cells in the K/BxN model
Immediate suspects were RF and anti-cII Abs. RF has be related to other arthritis models and to human RA
been considered a hallmark of RA in humans, but it patients? At first glance, an analogy might be made with
occurs in only about 70% of patients and its relevance CIA: both T and B cells are required for full disease
to disease has never been established (Vaughan, 1993). development (Taylor et al., 1995); serum anti-cII Abs
Anti-cII Abs are also found in RA patients, though there appear to have arthritogenic properties like the unidenti-
seems to be little correlation with disease parameters fied (non-anti-cII) Igs from K/BxN mice (Stuart and
(Claque and Moore, 1984; Rudolphi et al., 1997); more Dixon, 1983; Stuart and Dixon, 1982). However, serum
suggestively, injection of homologous or heterologous from animals with the cII-induced disease is quantita-
type II collagen into rodents elicits anti-cII T cell and Ab tively and qualitatively less potent: it requires larger
reactivity and provokes arthritis (Trentham and Dyne- amounts (about 10 times more than K/BxN serum), pro-
sius-Trentham, 1995). However, we have ruled out both vokes an evanescent disease (resolved in several days),
IgM isotype RF and anti-cII as the arthritogenic Abs in induces lesions more characteristic of the early stages
of arthritis (just synovial inflammation in the absenceK/BxN serum (Kouskoff et al., 1996; Figure 4F). This
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asymptomatic. Crossing these K/B animals with NOD/Lt (N) miceof significant cartilage and bone destruction), and only
generated arthritic K/BxN offspring. KRN TCR tg mice carrying theprecipitates disease in animals harboring T lymphocytes
mMo mutation, resulting in a lack of B cells when homozygous, have(Kadowaki et al., 1994; Taylor et al., 1995). It is also
been described (Kouskoff et al., 1996). The TCR-a (Cao; Philpott
important to keep in mind that CIA and the disease in et al., 1992) and RAG-1 (RAGo; Mombaerts et al., 1992) knockout
K/BxN mice are mechanistically different, the former mutations were each crossed onto both the B and N backgrounds,
induced by a classical Ab response centered on a single and in each case the two lines intercrossed to generate homozygous
mutant F1 animals. In some serum transfer experiments, RAGo/oAg, the latter by broad T and B cell stimulation. In fact,
mice on the standard Bx129 background were used. The CD40oit has recently been reported that injection of cII can
knockout mutation (Kawabe et al., 1994) was backcrossed in parallelinduce preliminary arthritic lesions even in the absence
to K/B and N mice, and the second-generation offspring were inter-of lymphocytes, raising the complication that cII may
crossed to generate K/BxN-CD40o/o animals or K/BxN-CD401/o con-
have nonantigenic arthritogenic properties (Plows et al., trol littermates. Similarly, the Ig knockin mutations, B1±8i and 3±83ki,
1999). Perhaps more relevant to the KRN model are the were backcrossed together to K/B and N mice in parallel; the sec-
pathogenesis of adjuvant-induced or reactive arthritis. ond-generation offspring were then intercrossed to generate
transgene-positive F1 animals with varying light and heavy chainIt is conceivable that the strong immune stimulation in
genotypes; some of these were further intercrossed to generatethese diseases activates T cells reactive to self-MHC
additional animals of desired genotypes. In all backcrosses to thecomplexes, and arthritis unfolds essentially as in the
N background, only breeders homozygous for the g7 haplotype atK/BxN model.
the MHC were used. Typing details for all lines can be found as
The relative importance of different leukocyte subsets supplemental data at http://www.immunity.com/cgi/content/full/10/
and their products in human RA remains the subject of 4/451/DC1. Arthritis was evaluated as described (Kouskoff et al.,
considerable debate. An early emphasis on B cells and 1996).
Flow cytometric analysis has been described; references totheir products (Zvaifler, 1973) gave way to a ªT cell-
monoclonal antibodies (mAbs) can be found in Cosgrove et al. (1991)centricº view (Panayi et al., 1992), which reigned for a
and Kouskoff et al. (1996).number of years but has recently been supplanted by
an emphasis on monocytes, dendritic cells, and the cy-
tokines they produce (Firestein and Zvaifler, 1990; Feld- Cell Transfers
mann et al., 1996a; Thomas and Lipsky, 1996; Burmester For splenocyte transfers, cell suspensions were made from pooled
spleens, depleted of erythrocytes in 0.83% NH4Cl for 5 min, andet al., 1997). A role for B cells in human RA was sug-
adjusted to 108/ml in RPMI. Cells (2 3 107) were injected i.v. intogested by the routine detection of autoantibodies, in
unirradiated recipients. In some cases, T cells were depleted byparticular RF (Vaughan, 1993), also sometimes anti-cII
complement killing (LoTox-M, Cederlane) after incubation with aand other anti-joint reactivities (Claque and Moore,
cocktail of mAbs (anti-Thy1, -CD4, and -CD8: J1-J, RL-172, and
1984; Rudolphi et al., 1997), and by the demonstration 31M). B cell±depleted splenocytes were obtained by magnetic sort-
of immune complexes suggestively localized in joint le- ing (anti-rat Ig Dynabeads, Dynal) after incubation with anti-B220
sions (Zvaifler, 1973). The emphasis on T cells derived and -MHC class II mAbs (RA3-6B2, M5/114). In some cases, CD41
and B2201 splenocytes were positively enriched with directly conju-from observations of a strong association of RA with
gated MACS beads (Miltenyi Biotech). For details of cell purifica-particular MHC alleles, the detection of activated T cells
tions, see http://www.immunity.com/cgi/content/full/10/4/451/DC1.in the joint, the demonstration of T cell reactivity to joint
To reconstitute B cells, BxN-Rago/o recipients were lightly irradiatedconstituents (including cII), and analogies with animal
(450 R) and injected i.v. with 5 3 106 bone marrow cells, positively
models of arthritis (Firestein and Zvaifler, 1990; Fox, purified on B220-conjugated MACS beads.
1997). However, any critical T cell function should oper- For the CFSE experiments, single-cell suspensions from pooled
ate in the early stages of disease because the T cells spleens of 6- to 10-week-old K/B mice were depleted of erythrocytes
in 0.83% NH4Cl for 1 min, adjusted to 107/ml in PBS, and incubatedin established lesions show little proliferative activity
for 10 min in the presence of 2.5 mM CFSE (Molecular Probes)and secrete few cytokines and because anti-T cell re-
prepared as a 5 mM stock solution in DMSO. After incubation, theagents seem to have little influence on ongoing arthritis
cells were washed twice with RPMI supplemented with 5% FCS(Firestein and Zvaifler, 1990; Fox, 1997). A central role
and adjusted to 1.5 3 108/ml. In each experiment, 300 ml (4.5 3 107
for macrophages or dendritic cells has been argued cells) were injected i.v. into adult recipients. At various times after
primarily on the basis of monokine imbalances in RA injection, axillary lymph nodes were removed and analyzed for the
patients and of strong disease inhibition after treatment presence of CFSE-labeled cells.
with anti-monokine reagents (e.g., anti-TNF-a and anti-
IL-1) (Feldmann et al., 1996a).
Serum TransfersIn analogy with the K/BxN model, we propose a syn-
Sera from paired lots of K/BxN mice or control BxN littermates (40
thesis of the data on human RA according to the follow- to 60 days of age) were pooled and injected intraperitonealy, in
ing scenario: T cell activation, perhaps pervasive, by an 150±250 ml total volume (adjusted with PBS if necessary). In most
unknown provocateur; T-B cell collaboration resulting cases, recipients got two injections at a 2 day interval.
in broad activation of B cells and autoantibody produc-
tion by a narrow ªsliceº of the repertoire; and Ab-precipi-
Ig Purificationtated joint lesions, amplified by locally produced mono-
Pooled sera from arthritic K/BxN or control BxN mice were cleared
kines, with little input from T cells. This scenario provides by ultracentrifugation (30 min at 58,000 rpm, SW60). Serum (5 ml)
a framework for experimental dissection of RA patho- from arthritic mice or 12 ml from control mice, diluted to 100 ml
genesis and for consideration of therapeutic strategies. with 50 mM Na phosphate (pH 7.5), was loaded onto a protein G
column (15 ml gel volume, Protein-G Sepharose, Pharmacia). The
flow-through was saved, and bound IgG was eluted in 0.1 M glycineExperimental Procedures
(pH 2.8) and quickly neutralized with 1/6 volume of 1 M Tris HCl (pH
8.5). The flow-through and pooled eluted fractions were concen-Mice and Cytofluorimetry
trated and switched to PBS buffer by centrifugation (Centricon-30,KRN TCR tg mice have been described (Kouskoff et al., 1996). They
were maintained on the C57Bl/6 (B) background and as such are Amicon).
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Measurement of Total and cII-Specific IgG Fulcher, D.A., Lyons, A.B., Korn, S.L., Cook, M.C., Koleda, C., Parish,
C., Fazekas de St Groth, B., and Basten, A. (1996). The fate of self-Serum IgG levels were measured by ELISA as described, using
reactive B cells depends primarily on the degree of antigen receptorreagents from Jackson Immunoresearch (Cosgrove et al., 1991);
engagement and availability of T cell help. J. Exp. Med. 183, 2313±optical density readings were normalized relative to standard curves
2328.obtained with sera from non-TCRtg littermates. Levels of serum
anti-cII IgG were also estimated by ELISA, on plates coated with Hannum, L.G., Ni, D., Haberman, A.M., Weigert, M.G., and Shlom-
type II collagen of bovine (Sigma C-7806) or rat origin (a gift from chik, M.J. (1996). A disease-related rheumatoid factor autoantibody
Dr R. Holmdhal, Lund, Sweden). Anti-cII titers were compared with is not tolerized in a normal mouse: implications for the origins of
a standard serum from DBA/1 mice with CIA (a gift from Dr. I. Camp- autoantibodies in autoimmune disease. J. Exp. Med. 184, 1269±
bell, Melbourne, Australia). 1278.
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